BeOne Medicines AG (SHA:688235)
China
· Delayed Price · Currency is CNY 279.25
-0.98 (-0.35%)
At close: Dec 5, 2025
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2014 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2014 - 2020 |
| U.S. Revenue | 2.64B | 1.96B |
Log In |
Log In |
Log In | Upgrade
|
| China Revenue | 1.64B | 1.41B |
Log In |
Log In |
Log In | Upgrade
|
| Europe Revenue | 552.63M | 362.63M |
Log In |
Log In |
Log In | Upgrade
|
| Rest of World Revenue | 149.15M | 78.81M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 4.97B | 3.81B |
Log In |
Log In |
Log In | Upgrade
|
Revenue
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2014 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2014 - 2020 |
| BRUKINSA Revenue | 3.61B | 2.64B |
Log In |
Log In |
Log In | Upgrade
|
| TEVIMBRA Revenue | 709.11M | 620.84M |
Log In |
Log In |
Log In | Upgrade
|
| XGEVA Revenue | 298.51M | 224.40M |
Log In |
Log In |
Log In | Upgrade
|
| BLINCYTO Revenue | 100.59M | 74.33M |
Log In |
Log In |
Log In | Upgrade
|
| KYPROLIS Revenue | 75.67M | 66.17M |
Log In |
Log In |
Log In | Upgrade
|
| POBEVCY Revenue | 48.60M | 53.51M |
Log In |
Log In |
Log In | Upgrade
|
| REVLIMID Revenue | - | 36.03M |
Log In |
Log In |
Log In | Upgrade
|
| VIDAZA Revenue | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Pamiparib Revenue | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Other Product Revenue | - | 60.04M |
Log In |
Log In |
Log In | Upgrade
|
| Total Other Product Revenue | 80.96M | 96.07M |
Log In |
Log In |
Log In | Upgrade
|
| Total Product Revenue | 4.92B | 3.78B |
Log In |
Log In |
Log In | Upgrade
|
| Collaboration Revenue | 49.03M | 30.70M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Other) | -4.92B | -3.78B |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 4.97B | 3.81B |
Log In |
Log In |
Log In | Upgrade
|